ABP 980

Generic Name: ABP 980
Study IDStudied Indication or DiseasePhaseStudy TitleSynopsis
20120283Subjects With HER2 Positive Early Breast Cancer3A Randomized, Double-blind, Phase 3 Study Evaluating the Efficacy and Safety of ABP 980 Compared With Trastuzumab in Subjects With HER2 Positive Early Breast Cancer
20130119NA1A Randomized, Single-Blind, Single-Dose, 3-Arm, Parallel Group Study to Determine the Pharmacokinetic Equivalence of ABP 980 and Trastuzumab (Herceptin®) in Healthy Male Subjects